Active ingredientBictegravirCat. No. P-B077-001CAS 1611493-60-7Family · Pharmaceutical analytical standards
Bictegravir
An HIV integrase inhibitor, blocking the enzyme the virus uses to insert its genetic material into the cell's DNA. Approved in 2018 in the United States and Europe, it comes in a single tablet together with emtricitabine and tenofovir alafenamide. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?Unlike some earlier integrase inhibitors such as elvitegravir, it does not need a pharmacokinetic booster such as ritonavir or cobicistat to keep effective levels in the blood.
Go to the active ingredient →Active ingredientBictegravirCat. No. P-B077-001CAS 1611493-60-7
Active ingredientBictegravir SodiumCat. No. P-B077-002CAS 1807988-02-8
MetaboliteBictegravir Metabolite 1Cat. No. P-B077-003CAS 2365156-60-9
Isotopically labelledBictegravir-D5Cat. No. P-B077-005
Impurity2,4,6-TrifluorobenzylamineCat. No. P-B077-007CAS 214759-21-4
ImpurityBictegravir 13 aS isomerCat. No. P-B077-008
ImpurityBictegravir 2,4-Difluoro ImpurityCat. No. P-B077-009CAS 1611493-56-1
ImpurityBictegravir EnantiomerCat. No. P-B077-010CAS 1616340-12-5
ImpurityBictegravir Impurity 1Cat. No. P-B077-012CAS 2411506-35-7
ImpurityBictegravir Impurity 2Cat. No. P-B077-013CAS 2411506-37-9
ImpurityBictegravir Impurity 3Cat. No. P-B077-014CAS 1616342-45-0
ImpurityBictegravir Impurity 4 HydrochlorideCat. No. P-B077-016CAS 1523530-42-8
ImpurityBictegravir Impurity 5Cat. No. P-B077-017CAS 1335210-23-5
ImpurityBictegravir Impurity 6Cat. No. P-B077-020CAS 1616339-82-2
Impuritycis-3-AminocyclopentanolCat. No. P-B077-025CAS 1110772-05-8
ImpurityHydroxy-bictegravirCat. No. P-B077-026CAS 2365156-62-1
ImpurityMethyl BictegravirCat. No. P-B077-027CAS 1616340-94-3
Impurityrac-(1R,3R)-3-aminocyclopentan-1-ol hydrochlorideCat. No. P-B077-028CAS 124555-33-5
Impurityrac-(1R,3S)-3-aminocyclopentan-1-olCat. No. P-B077-029CAS 1036260-18-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.